Brief Article
Copyright ©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 14, 2010; 16(38): 4838-4845
Published online Oct 14, 2010. doi: 10.3748/wjg.v16.i38.4838
Figure 2
Figure 2 Changes in aspartate aminotransferase. The aspartate aminotransferase (AST) level in the erythropoietin (EPO)1 group was significantly lower than that in the steroid (STRD) group on Day 0 (P = 0.041, Kruskal-Wallis test), and also significantly lower than that in the STRD and EPO2 groups on Day 1 (P = 0.018, Kruskal-Wallis test). There were no significant differences in the AST level after Day 3. Note that the scale of the Y-axis differs in each graph. SS: Statistically significant.